Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 9 studies | 23% ± 7% | |
| glutamatergic neuron | 4 studies | 34% ± 11% | |
| interneuron | 4 studies | 26% ± 10% | |
| GABAergic neuron | 4 studies | 37% ± 12% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 28% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 32% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 809.08 | 2559 / 2642 | 81% | 9.36 | 572 / 705 |
| uterus | 90% | 315.93 | 153 / 170 | 67% | 12.18 | 309 / 459 |
| bladder | 67% | 377.48 | 14 / 21 | 70% | 12.58 | 353 / 504 |
| prostate | 87% | 337.41 | 212 / 245 | 31% | 2.65 | 155 / 502 |
| ovary | 99% | 2079.28 | 179 / 180 | 16% | 1.18 | 70 / 430 |
| pancreas | 95% | 357.76 | 311 / 328 | 20% | 2.17 | 35 / 178 |
| adrenal gland | 40% | 65.78 | 103 / 258 | 64% | 27.45 | 148 / 230 |
| kidney | 98% | 470.96 | 87 / 89 | 6% | 0.82 | 52 / 901 |
| lung | 25% | 34.14 | 143 / 578 | 79% | 23.06 | 907 / 1155 |
| esophagus | 49% | 299.03 | 712 / 1445 | 52% | 10.18 | 95 / 183 |
| ureter | 0% | 0 | 0 / 0 | 100% | 19.87 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 16.17 | 38 / 45 |
| stomach | 46% | 176.60 | 165 / 359 | 33% | 6.38 | 95 / 286 |
| muscle | 78% | 228.67 | 628 / 803 | 0% | 0 | 0 / 0 |
| breast | 39% | 69.36 | 179 / 459 | 32% | 4.58 | 357 / 1118 |
| intestine | 20% | 25.75 | 198 / 966 | 46% | 8.47 | 245 / 527 |
| thymus | 11% | 12.82 | 75 / 653 | 49% | 13.07 | 298 / 605 |
| skin | 7% | 7.79 | 120 / 1809 | 19% | 3.54 | 89 / 472 |
| heart | 13% | 21.97 | 109 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 12% | 2.07 | 49 / 406 |
| adipose | 7% | 8.64 | 81 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 4% | 6.03 | 53 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.48 | 3 / 80 |
| peripheral blood | 0% | 0.08 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0015015 | Biological process | heparan sulfate proteoglycan biosynthetic process, enzymatic modification |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0017095 | Molecular function | heparan sulfate 6-O-sulfotransferase activity |
| Gene name | HS6ST2 |
| Protein name | Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST-2) (EC 2.8.2.-) Heparan-sulfate 6-O-sulfotransferase (EC 2.8.2.-) |
| Synonyms | PSEC0092 |
| Description | FUNCTION: 6-O-sulfation enzyme which catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to position 6 of the N-sulfoglucosamine residue (GlcNS) of heparan sulfate. . FUNCTION: 6-O-sulfation enzyme which catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to position 6 of the N-sulfoglucosamine residue (GlcNS) of heparan sulfate. . |
| Accessions | ENST00000640529 ENST00000521489.5 [Q96MM7-4] ENST00000370836.6 [Q96MM7-1] A0A1W2PQ14 ENST00000406696.5 [Q96MM7-3] Q96MM7 ENST00000370833.7 [Q96MM7-4] ENST00000640529.2 [Q96MM7-3] |
